Dopamine may be factor in chronic pain, study says | Poor sleep quality may affect pain sensitivity, study says | Vocalizing pain improves tolerance in study
 
Advertisement
 
May 13, 2015
News for the pain professional
SIGN UP|FORWARD|ARCHIVE|ADVERTISE

Pain Research NewsAdvertisement
Dopamine may be factor in chronic pain, study says
Dopamine may be an important factor in maintaining chronic pain, researchers reported in the Journal of Neuroscience. The study found a group of cells that contained the brain chemical did not have a role in acute pain but targeting them with a toxin did reduce chronic pain in mice. Medical News Today (5/11)
Share: LinkedInTwitterFacebookGoogle+Email
Poor sleep quality may affect pain sensitivity, study says
A Norwegian study that included more than 10,000 adults links poor sleep quality with greater sensitivity to pain. Researchers wrote in the journal Pain that severity of insomnia correlated with levels of pain sensitivity. HealthDay News (5/12)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
CMS Open Payments: What You Need to Know
As part of CMS Open Payments, manufacturers and GPOs submitted data about their financial relationships with you—physicians and teaching hospitals. You are encouraged to review that data before it is made available on a publicly accessible website. Learn more now!
Advertisement
 
Treatment NewsAdvertisement
Implant offers targeted relief for back pain
Back
(Anna Zieminski/AFP/Getty Images)
A small polymer tube may provide a more targeted alternative to pills for back pain sufferers. The medication-containing device developed in Sweden is implanted near the source of pain and dispenses doses of its contents when stimulated externally in response to an electrical current. LiveScience.com (5/8)
Share: LinkedInTwitterFacebookGoogle+Email
 
Nevro lands FDA approval for Senza spinal cord stimulation system
The Senza system, Nevro's device that relieves trunk or limb pain without paresthesia by sending electrical pulses to the spinal cord, has received approval from the FDA. The agency based its approval on a clinical study showing that three-fourths of participants being treated with the device reported their pain was cut in half within three months. Among the adverse events found with the use of Senza were implant site pain and device lead dislocation. Medscape (free registration) (5/8)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Watch this CME/CE Webcast as faculty debate and discuss safety and benefit considerations that influence decision making in the surgical setting. They also present strategies for effective communication among anesthesiologists, certified registered nurse anesthetists, and pharmacists regarding patient needs and economic factors. WATCH TODAY
Advertisement
 
Policy & Trends
Fewer new moms get codeine prescriptions, study says
A study in the Journal of the American Medical Association said a warning that codeine taken by women who are breast-feeding may raise the risk of overdose among infants has been followed by reductions in the number of new mothers getting prescriptions for the drug. While codeine prescriptions have decreased, scripts for other opioid medications, such as oxycodone, tramadol and hydromorphone increased. PhysiciansBriefing.com/HealthDay News (5/12)
Share: LinkedInTwitterFacebookGoogle+Email
Mass. amnesty program to offer treatment to addicts
Police in Gloucester, Mass., say they will allow people who are addicted to turn in their drugs at the police station without being charged as long as they agree to get treatment. The program will provide an "angel" to help guide people through the treatment process, and some pharmacies are providing Narcan, which reverses an opioid overdose, for little or no charge. The Huffington Post (5/12)
Share: LinkedInTwitterFacebookGoogle+Email
FEATURED ARTICLE: Understanding the Power of the Pareto Principle
Here's how the Pareto Principle, also known as the 80-20 rule, can show you which customers you should spend the most time with. Read the article to learn more.
Advertisement

APS News
National Pain Strategy comment deadline is next week
The Interagency Pain Research Coordinating Committee, which falls under the National Institute of Neurological Disorders and Stroke, was charged by the Office of the Assistant Secretary for Health to create a comprehensive population health level-strategy for pain prevention, management, research, and treatment. Public comments on the National Pain Strategy draft are due Wednesday, May 20. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
Now open: 2016 call for symposia
Are you interested in presenting your research to multidisciplinary pain researchers and clinicians? This is your chance to do so! The APS Scientific Program Committee invites you to submit your proposals for presentations. Submitted proposals must reflect APS' multidisciplinary approach to pain and should include presenting the areas of pain science, translational research, and treatment. Shared Interest Groups (SIGs) are also invited to submit formal proposals for their 2016 SIG meetings for continuing education credit. The 35th Annual Scientific Meeting will be held in Austin, May 11-14. Submissions deadline is Monday, July 20. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
SmartQuote
The great aim of education is not knowledge but action."
-- Herbert Spencer,
philosopher and sociologist
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about APS ->Membership | Annual Meeting | Education | Funding Opportunities | About Us
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Tom Parks
Advertising:  Wynn Hansen
  P: 202.470.1149
 
 

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information